Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

606
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
606
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

1.6K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association of epiretinal membranes with disability in people with multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

Metabolomic Signatures of Brain Atrophy and Ibudilast Response in Progressive Multiple Sclerosis.

medRxiv : the preprint server for health sciences·2026
Same author

Proteomic Age Acceleration in Multiple Sclerosis Precedes Symptom Onset and Associates with Severity.

medRxiv : the preprint server for health sciences·2026
Same author

Accelerometry-derived activity fragmentation as a predictor of brain atrophy and disability progression in multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

Cardiovascular comorbidities are associated with cross-sectional and longitudinal measures of multiple sclerosis fatigue.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

Influence of OSCAR-IB criteria on test-retest reliability of Spectralis SD-OCT retinal thickness measurements in people with Multiple Sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026

Related Experiment Video

Updated: Jul 24, 2025

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord
10:44

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord

Published on: February 22, 2015

10.3K

Multiple Sclerosis Pathogenesis and Updates in Targeted Therapeutic Approaches.

Eleni S Vasileiou1, Kathryn C Fitzgerald2,3

  • 1Department of Neurology, Johns Hopkins University, Baltimore, MD, USA.

Current Allergy and Asthma Reports
|July 4, 2023
PubMed
Summary

This review updates on multiple sclerosis (MS) advances. New therapies like Bruton tyrosine kinase (BTK) inhibitors and insights into Epstein-Barr virus (EBV) offer hope for managing this CNS disorder.

Keywords:
DMT in MSEBV in MSImmunomodulatory therapiesMS contributorsMS pathogenesisMS risk factorsMS therapeutic advancementsMS therapiesMultiple sclerosis

More Related Videos

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research
05:55

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

Published on: December 1, 2023

890
Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

3.7K

Related Experiment Videos

Last Updated: Jul 24, 2025

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord
10:44

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord

Published on: February 22, 2015

10.3K
Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research
05:55

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

Published on: December 1, 2023

890
Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

3.7K

Area of Science:

  • Neurology
  • Immunology
  • Pharmacology

Background:

  • Multiple sclerosis (MS) is a primary cause of non-traumatic disability in young adults.
  • Characterized by central nervous system (CNS) inflammation and degeneration.
  • Advances in understanding disease mechanisms drive therapeutic development.

Purpose of the Study:

  • Provide a comprehensive update on scientific advances in multiple sclerosis.
  • Highlight emerging therapeutic approaches for MS.
  • Overview of MS pathophysiology and recent treatment interventions.

Main Methods:

  • Literature review of current scientific advances.
  • Analysis of emerging therapeutic strategies.
  • Synthesis of research on MS pathophysiology and treatment.

Main Results:

  • Bruton tyrosine kinase (BTK) inhibitors show promise as a new immunomodulatory treatment.
  • Epstein-Barr virus (EBV) is increasingly recognized as a key factor in MS.
  • Research is expanding to understand non-inflammatory drivers of MS pathogenesis.

Conclusions:

  • MS pathogenesis is complex, requiring multifaceted intervention strategies.
  • Recent therapeutic advancements target inflammatory components of MS.
  • Continued research is crucial for addressing knowledge gaps in MS.